ELIXF Stock Chart & Stats
$0.03
$0.00(0.00%)
At close: 4:00 PM EST
$0.03
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.10
Previous CloseN/A
Volume1.00
Average Volume (3M)1.47K
Market Cap
$2.06M
Enterprise Value$25.62
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.43
Next Earnings
Nov 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding95,263,040
10 Day Avg. Volume0
30 Day Avg. Volume1,474
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap<0.01
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Elixxer News
ELIXF FAQ
What was Elixxer’s price range in the past 12 months?
Elixxer lowest stock price was $0.01 and its highest was $0.10 in the past 12 months.
What is Elixxer’s market cap?
Elixxer’s market cap is $2.06M.
When is Elixxer’s upcoming earnings report date?
Elixxer’s upcoming earnings report date is Nov 19, 2026 which is in 83 days.
How were Elixxer’s earnings last quarter?
Currently, no data Available
Is Elixxer overvalued?
According to Wall Street analysts Elixxer’s price is currently Overvalued.
Does Elixxer pay dividends?
Elixxer does not currently pay dividends.
What is Elixxer’s EPS estimate?
Elixxer’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Elixxer have?
Elixxer has 95,263,040 shares outstanding.
What happened to Elixxer’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Elixxer?
Currently, no hedge funds are holding shares in ELIXF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Elixxer
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cannabis-related businesses, which are fully licensed for cultivation, production, and/or sale of medical and specialty cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.